Biotech Values

[mcbio]

Yes, it does matter because decision are being made on grossly over-inflated numbers resulting in ridiculous valuations.

So, do you think Medivir has a "ridiculous valuation" at a ~$300M market cap with the most advanced 2nd gen PI, particularly if TMC435 shows positive Phase 2 results in its combo trial with GS-7977 later this year?